Financials
- Market Capitalization 6.81 M
- Employee 5
- Founded 2018
- CEO N/A
- Website www.ernexatx.com
- Headquarter Delaware, United States
- FIGI BBG000CX5677
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
1.01
ratio cours/chiffre d'affaires
376.2
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4826 | INM InMed Pharmaceuticals Inc. - Common Shares | 1.30 USD | -0.76% | -4.41% | -10.96% | -39.53% | 7.14 M USD | ||
| 4828 | CURX Curanex Pharmaceuticals Inc - Common Stock | 4.52 USD | +5.12% | -11.37% | +1865.22% | -45.41% | 7.09 M USD | ||
| 4844 | AIM AIM ImmunoTech Inc. Common Stock | 0.22 USD | -4.35% | -4.35% | -15.38% | -91.57% | 6.70 M USD | ||
| 4848 | LEXX Lexaria Bioscience Corp. - Common Stock | 3.97 USD | -1.98% | -64.20% | -33.28% | +230.83% | 6.56 M USD |